In a placebo-controlled trial, the effect of the PDE5 inhibitor tadalafil for 6 weeks on the finger RHI was examined in recently diagnosed, well-controlled patients with T2D [36]. This evidence concerns the gene PDE5A and type 2 diabetes mellitus.